Pozen Announces Trexima (Sumatriptan Succinate and Naproxen Sodium ... - PharmaLive.com (press release)
March 23, 2007| Pozen Announces Trexima (Sumatriptan Succinate and Naproxen Sodium ... PharmaLive.com (press release), PA - Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. ... FDA Approves To Review Amended Response Of Pozen's Trexima - Update Pozen Reports Trexima Amended Response Accepted For Review By FDA ... |
POZEN Announces Trexima™ Amended Response Accepted for Review by FDA - Carolina Newswire (press release)
March 23, 2007| POZEN Announces Trexima™ Amended Response Accepted for Review by FDA Carolina Newswire (press release), NC - Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. ... |